Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 14/20 | 0.38 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21685572 | 0.92 | NR1H2 (0.39) | NR1H2TRPV3FAAHNR1H3CA12 | |
| SCHEMBL28721362 | 0.79 | NR1H2 (0.44) | NR1H2FAAHNR1H3CA12CA9 | |
| SCHEMBL4716718 | 0.77 | BRD4 (0.44) | NR1H2FAAHNR1H3BRD4 | |
| SCHEMBL21684480 | 0.74 | PPARG (0.39) | NR1H2TRPV3FAAHNR1H3 | |
| SCHEMBL21685279 | 0.74 | MAP4K1 (0.41) | NR1H2 | |
| SCHEMBL368032 | 0.73 | CYP1A2 (0.45) | NR1H2FAAHNR1H3 | |
| SCHEMBL21685654 | 0.71 | MAP4K1 (0.45) | NR1H2 | |
| SCHEMBL21684342 | 0.71 | ELANE (0.40) | NR1H2 | |
| SCHEMBL21684352 | 0.70 | FAAH (0.38) | NR1H2TRPV3FAAHNR1H3 | |
| SCHEMBL21685143 | 0.70 | MAP4K1 (0.47) | NR1H2FAAHNR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4219460-A1 | TRANSGLUTAMINASE 2 (TG2) INHIBITORS | Sitari Pharma, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| WO-2020033784-A1 | TRANSGLUTAMINASE 2 (TG2) INHIBITORS | SITARI PHARMA, INC. (US) | 2020-02-13 | — | — | WO | disclosed |